UiPath (PATH) Research & Development (2020 - 2026)

UiPath (PATH) has reported Research & Development for 7 consecutive years, with $167.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development rose 5.13% year-over-year to $167.9 million; the trailing twelve-month figure through Apr 2026 stood at $691.5 million (down 3.69% YoY), and the FY2026 full-year result was $683.3 million, down 7.47% from the prior year.
• Research & Development fell to $167.9 million in Q2 2026 per PATH's latest filing, from $178.2 million in the prior quarter.
• Across five years, Research & Development topped out at $194.3 million in Q3 2024 and bottomed at $156.5 million in Q4 2022.
• Historically, Research & Development has averaged $176.6 million across 5 years, with a median of $177.5 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Research & Development soared 75.85% in 2022, then decreased 15.48% in 2023.
• Over 5 years, Research & Development stood at $156.5 million in 2022, then grew by 22.25% to $191.3 million in 2023, then slipped by 2.14% to $187.2 million in 2024, then decreased by 4.27% to $179.2 million in 2025, then declined by 6.32% to $167.9 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $167.9 million, $178.2 million, and $179.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.